Element Biosciences, a company that develops a new innovative DNA sequencing platform, has announced the launch of its Element AVITI System, a benchtop sequencer that allows users to quickly access information. Both the accuracy, throughput, and cost efficiency are among the key components of the system, according to Molly Levy, the CEO of Element Biosciences. With the announcement, the system will now offer both short and long-read capabilities as per the audience.
Proprietary Chemistries: Delivers exceptional sequencing accuracy while dramatically reducing operating costs and eliminating index misassignments due to amplification State of the Art Performance: Accuracy and output metrics that enable a broad spectrum of demanding NGS applications Random Access Dual Flow Cells: Scalable output and batch control capabilities; equivalent to having two sequencing systems in one Simple NGS library prep compatibility Open Informatics: FASTQ file output without proprietary requirements for analysis
Principal Operating Standards
The Element AVITI System is based on a single flow cell and sequencing reactor cartridge design that provides up to 300 cycles and tunable read throughput control for each of two independently operated flow cells. This allows the user to complete run control timing and scalability without being exposed from the order and inventory complexity of multiple kit sizes. AVITI Instrument Pricing: $289,000 *Range determined by flow cell output, which can exceed 1000M paired-end reads per run